SmithKline Beecham’s Eminase
Executive Summary
Price to U.S. hospitals for recently approved injectable thrombolytic agent is $1,700 per dose. Shipments expected to begin this week. Genentech's infusable TPA product, Activase, is priced at $2,000-$2,200 per dose.